A Phase 1b Proof-of-concept Trial Exploring the Effects of FE 999322 and FE 999324 in Adults With Mild to Moderate Ulcerative Colitis
Public ClinicalTrials.gov record NCT06260267. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
To explore the safety of FE 999322 (microbiota suspension) and FE 999324 (microbiota capsule) versus placebo in subjects with active mild to moderate ulcerative colitis (UC).
Study identification
- NCT ID
- NCT06260267
- Recruitment status
- Withdrawn
- Study type
- Interventional
- Phase
- Phase 1
- Enrollment
- Not listed
Conditions and interventions
Conditions
Interventions
- Microbiota suspension Drug
- Microbiota capsule Drug
- Placebo suspension Drug
- Placebo capsule Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Mar 12, 2024 (Actual)
- Primary completion
- Jan 15, 2026 (Estimated)
- Completion
- Jan 15, 2026 (Estimated)
- Last update posted
- Oct 18, 2024
2024 – 2026
United States locations
- U.S. sites
- 10
- U.S. states
- 7
- U.S. cities
- 10
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Ferring Investigational Site | North Little Rock | Arkansas | 72117 | — |
| Ferring Investigational Site | Hamden | Connecticut | 06518 | — |
| Ferring Investigational Site | Inverness | Florida | 34452 | — |
| Ferring Investigational Site | Jacksonville | Florida | 32256 | — |
| Ferring Investigational Site | Orange City | Florida | 32763 | — |
| Ferring Investigational Site | Glenview | Illinois | 60026 | — |
| Ferring Investigational Site | Gurnee | Illinois | 60031 | — |
| Ferring Investigational Site | Shreveport | Louisiana | 71105 | — |
| Ferring Investigational Site | Boston | Massachusetts | 02115 | — |
| Ferring Investigational Site | Oklahoma City | Oklahoma | 73102 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT06260267, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Oct 18, 2024 · Synced Nov 2, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT06260267 live on ClinicalTrials.gov.